Postpartum patients have slightly prolonged neuromuscular block after mivacurium

Anesth Analg. 1998 Jan;86(1):82-5. doi: 10.1097/00000539-199801000-00016.

Abstract

Postpartum patients have decreased plasma cholinesterase activity, which may slow the metabolism of mivacurium. We compared the duration of a mivacurium neuromuscular block in 11 women undergoing postpartum tubal ligation 36-99 h after delivery with that in 11 control women undergoing gynecological surgery. Anesthesia was induced with propofol and fentanyl and maintained with propofol and nitrous oxide. Neuromuscular block was monitored by electromyography, and the ulnar nerve was stimulated transcutaneously using a train-of-four pattern. Patients received a bolus dose of mivacurium 0.15 mg/kg. The median (range) duration of neuromuscular block until 25% recovery of the first twitch response was longer in the postpartum group, 19.4 (15.6-25.2) min, compared with the control group, 16.3 (11.0-23.4) min (P = 0.04). The median (range) plasma cholinesterase activity was decreased in the postpartum group, 4.0 (0.1-5.5) kU/L, compared with the control group, 7.1 (6.2-10.0) kU/L (P < 0.001). The duration of neuromuscular block was inversely correlated with cholinesterase activity (Kendall rank correlation tau = -0.43, P = 0.005). The slight prolongation of neuromuscular block should not be significant clinically.

Implications: Postpartum patients have decreased amounts of the plasma cholinesterase enzyme. This would slow the metabolism of the muscle relaxant mivacurium. However, the duration of muscle paralysis is only prolonged by approximately 3 min, which would not normally cause any significant problems.

MeSH terms

  • Adult
  • Female
  • Humans
  • Isoquinolines / pharmacology*
  • Middle Aged
  • Mivacurium
  • Neuromuscular Junction / drug effects*
  • Neuromuscular Nondepolarizing Agents / pharmacology*
  • Postpartum Period / physiology*
  • Pregnancy
  • Time Factors

Substances

  • Isoquinolines
  • Neuromuscular Nondepolarizing Agents
  • Mivacurium